ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

32,508Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 1185

$1.86M Total Retail Price of All Prescriptions

Rank: 2 out of 1185

893 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 893 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 893 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 27,608 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
LISINOPRIL 1,289 1,156 1 4
AMLODIPINE BESYLATE 1,087 967 2 1
LEVOTHYROXINE SODIUM 906 818 3 3
FUROSEMIDE 856 791 4 8
METOPROLOL TARTRATE 807 687 5 10
PRAVASTATIN SODIUM 704 629 6 7
NAMENDA 684 666 7 43
POTASSIUM CHLORIDE 679 618 8 18
DONEPEZIL HCL 614 595 9 32
METFORMIN HCL 606 524 10 9
OMEPRAZOLE 569 488 11 6
CITALOPRAM HBR 559 476 12 22
LOSARTAN POTASSIUM 550 513 13 26
CARVEDILOL 477 443 14 24
RANITIDINE HCL 474 394 15 17
ATORVASTATIN CALCIUM 466 362 16 11
HYDROCHLOROTHIAZIDE 430 369 17 12
SIMVASTATIN 423 365 18 5
HYDROCODONE-ACETAMINOPHEN 421 354 S3 19 2
LANTUS 389 357 20 66
HYDRALAZINE HCL 367 334 21 112
METOPROLOL SUCCINATE 359 333 22 20
DIVALPROEX SODIUM 337 298 23 96
POLYETHYLENE GLYCOL 3350 330 317 24 60
FAMOTIDINE 325 288 25 69
ALLOPURINOL 324 304 26 30
LISINOPRIL-HYDROCHLOROTHIAZIDE 301 249 27 14
GABAPENTIN 298 224 28 13
WARFARIN SODIUM 277 249 29 21
FENTANYL 254 242 S2 30 107
METFORMIN HCL ER 252 219 31 35
RISPERIDONE 248 203 32 72
ATENOLOL 244 237 33 28
CYMBALTA 241 178 34 44
QUETIAPINE FUMARATE 234 202 35 93
JANTOVEN 230 181 36 136
CLONIDINE HCL 230 175 36 47
NEXIUM 229 178 38 19
ESCITALOPRAM OXALATE 221 191 39 79
SPIRIVA 218 191 40 64
TRAMADOL HCL 212 194 41 16
CLOPIDOGREL 206 173 42 31
DIOVAN 201 177 43 37
DIGOXIN 183 177 44 67
ADVAIR DISKUS 183 132 44 54
TAMSULOSIN HCL 180 136 46 34
NOVOLOG 177 160 47 127
PRADAXA 176 158 48 249
ISOSORBIDE MONONITRATE ER 176 173 48 48
LOSARTAN-HYDROCHLOROTHIAZIDE 176 154 48 36
SERTRALINE HCL 165 120 51 25
IPRATROPIUM-ALBUTEROL 160 126 52 164
JANUVIA 159 136 53 68
PROMETHAZINE HCL 157 122 R 54 76
MEGESTROL ACETATE 156 151 R 55 170
TRAZODONE HCL 155 105 56 38
PREDNISONE 151 130 57 33
PHENYTOIN SODIUM EXTENDED 143 131 58 111
TRAVATAN Z 139 135 59 230
PLAVIX 139 121 59 45
CIPROFLOXACIN HCL 136 115 61 62
CRESTOR 136 77 61 23
SINGLE USE SWAB 134 129 63 178
GLIMEPIRIDE 133 113 64 49
MIRTAZAPINE 124 108 65 57
LEVOFLOXACIN 121 101 66 109
BENAZEPRIL HCL 117 113 67 41
PAROXETINE HCL 117 77 67 73
EXELON 115 108 69 120
ZOLPIDEM TARTRATE 115 62 69 15
SPS 107 107 71 268
FLUTICASONE PROPIONATE 106 76 72 29
INSULIN SYRINGE 105 105 73 90
SULFAMETHOXAZOLE-TRIMETHOPRIM 104 81 74 91
COLCRYS 103 59 75 110
AMITIZA 102 57 76 218
PANTOPRAZOLE SODIUM 101 85 77 58
CEPHALEXIN 100 81 78 103
DIOVAN HCT 99 75 79 46
HUMALOG 98 78 80 210
FLUOXETINE HCL 97 62 81 52
LEVEMIR 92 76 82 162
ALENDRONATE SODIUM 91 91 83 40
LOVASTATIN 91 89 83 63
OXYCODONE HCL 90 72 S2 85 70
OLANZAPINE 89 73 86 156
LEVETIRACETAM 89 46 86 131
GLIPIZIDE 86 79 88 56
CARBIDOPA-LEVODOPA 86 84 88 142
PHENYTOIN 85 62 90 232
NAPROXEN 83 61 91 92
NYSTATIN 83 72 91 197
AMITRIPTYLINE HCL 83 51 R 91 51
AMIODARONE HCL 79 73 94 248
SPIRONOLACTONE 78 51 95 75
SEROQUEL 77 69 96 159
BENZTROPINE MESYLATE 76 39 R 97 180
LYRICA 75 60 98 74
MONOJECT INSULIN SYRINGE 74 74 99 276
HALOPERIDOL 73 56 100 229
VENLAFAXINE HCL ER 72 40 101 105
BUSPIRONE HCL 70 64 102 148
ABILIFY 69 39 103 192
BYSTOLIC 69 62 103 114
NIFEDIPINE ER 66 59 105 97
AMLODIPINE BESYLATE-BENAZEPRIL 65 46 106 42
LANTUS SOLOSTAR 63 36 107 104
RENVELA 61 37 108 369
VALPROIC ACID 58 48 109 213
ZIPRASIDONE HCL 58 58 109 376
RIVASTIGMINE 57 50 111 282
EXFORGE 56 55 112 161
SINGULAIR 56 33 112 106
PRISTIQ ER 53 27 114 390
AMOX TR-POTASSIUM CLAVULANATE 53 45 114 140
OXYBUTYNIN CHLORIDE 51 40 116 149
PROAIR HFA 51 25 116 50
LATANOPROST 51 51 116 274
COMBIVENT 51 25 116 124
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 9, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.